- PAHC Ticker
- 🇺🇸 NASDAQ 兑换
- 1,500 员工
- 💊 Health Care 部门
- 👩🏻⚕ Pharmaceuticals 工业
- Jack C. Bendheim 首席执行官
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
财务报表 — Phibro Animal Health
这些信息不是100%最新的。可能存在错误或信息缺失。有些信息经常丢失,虽然几乎没有错误,但我不能排除它们。现在,我正在寻找一个高质量的信息供应商,但到目前为止,我发现的是昂贵的(大约2000美元一年)。您可以帮助我的项目这里。
损益表
资产负债表
现金流动
20 ← 16 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|
總收入 |
|
800M | 830M | 820M | 760M | 750M |
收益成本 |
|
540M | 560M | 550M | 520M | 510M |
毛利 |
|
260M | 260M | 270M | 250M | 240M |
研究與開發 |
|
0 | 0 | 0 | 0 | 0 |
出售一般和管理員 |
|
190M | 180M | 170M | 150M | 150M |
運營開支 |
|
730M | 740M | 720M | 670M | 670M |
營業收入 |
|
69M | 83M | 99M | 98M | 86M |
其他收入支出淨額 |
|
0 | 0 | 0 | 0 | 0 |
EBIT |
|
69M | 83M | 99M | 98M | 86M |
利息收入 |
|
13M | 12M | 12M | 15M | 17M |
稅前收入 |
|
56M | 72M | 88M | 81M | 77M |
所得稅 |
|
22M | 17M | 23M | 16M | -6M |
少數權益 |
|
0 | 0 | 0 | 0 | 0 |
淨收入 |
|
34M | 55M | 65M | 65M | 83M |
淨收入基本 |
|
34M | 55M | 65M | 65M | 83M |
20 ← 16 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|
當前現金 |
|
91M | 82M | 79M | 56M | 34M |
短期投資 |
|
37M | 27M | 22M | 21M | 18M |
應收款 |
|
130M | 160M | 140M | 130M | 120M |
庫存 |
|
200M | 200M | 180M | 160M | 170M |
其他流動資產 |
|
37M | 27M | 22M | 21M | 18M |
當前資產 |
|
450M | 470M | 420M | 360M | 340M |
長期投資 |
|
330M | 260M | 260M | 260M | 270M |
物業設備 |
|
150M | 140M | 130M | 130M | 130M |
商譽 |
|
53M | 27M | 27M | 24M | 21M |
無形資產 |
|
71M | 47M | 52M | 55M | 60M |
其他資產 |
|
16M | 19M | 22M | 21M | 22M |
總資產 |
|
780M | 730M | 670M | 620M | 610M |
應付賬款 |
|
66M | 73M | 59M | 57M | 60M |
當前長期債務 |
|
19M | 13M | 13M | 6.3M | 2.8M |
其他流動負債 |
|
72M | 68M | 71M | 53M | 46M |
總流動負債 |
|
160M | 150M | 140M | 120M | 110M |
長期債務 |
|
370M | 310M | 300M | 310M | 350M |
其他負債 |
|
53M | 43M | 44M | 50M | 61M |
少數權益 |
|
0 | 0 | 0 | 0 | 0 |
負債總額 |
|
600M | 510M | 490M | 470M | 520M |
普通股 |
|
40M | 40M | 40M | 40M | 39M |
留存收益 |
|
180M | 170M | 130M | 83M | 34M |
庫存庫存 |
|
0 | 0 | 0 | 0 | 0 |
資本盈餘 |
|
• | • | • | • | • |
股東權益 |
|
190M | 220M | 180M | 150M | 90M |
有形淨資產 |
|
65M | 140M | 110M | 73M | 9.3M |
20 ← 16 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|
淨收入 |
|
34M | 55M | 65M | 65M | 83M |
折舊 |
|
32M | 28M | 27M | 26M | 23M |
應收款變動 |
|
-33M | 23M | 9.9M | 2.1M | 13M |
庫存變化 |
|
-1.7M | 20M | 17M | -6.5M | 18M |
現金找零 |
|
9.8M | 2.4M | 23M | 22M | 4.4M |
現金流量 |
|
59M | 47M | 70M | 98M | 37M |
資本支出 |
|
-34M | -30M | -19M | -21M | -36M |
投資 |
|
• | • | • | • | • |
投資其他活動 |
|
• | • | • | • | • |
總投資現金流量 |
|
-120M | -14M | -85M | -22M | -83M |
已付股息 |
|
19M | • | • | • | • |
淨借款 |
|
260M | 220M | 210M | 240M | 300M |
其他籌資現金流量 |
|
• | • | • | • | • |
現金流量融資 |
|
41M | -4.1M | -12M | -54M | 50M |
匯率影響 |
|
• | • | • | • | • |
制造和销售动物保健药品和营养产品